Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 30 2023 - AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Biopharma’s top 5 IPOs of 2023 so far
Astellas builds case for menopause drug fezolinetant
Boehringer Ingelheim to collaborate with Phenomic AI on stroma-rich cancers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Big pharma's top lobbyist said what?

The Atlantic

Friday, March 6, 2009 - 1:34pm

tags:

Big Pharma, Billy Tauzin, PhRMA

Bad economy may boost insomnia meds

Fierce Pharma

Friday, March 6, 2009 - 1:32pm

tags:

insomnia, economy

Forest Laboratories delays launch of fibromyalgia drug Savella; lung drug to get more testing

Yahoo/AP

Friday, March 6, 2009 - 12:59pm

tags:

Forest Labs, Savella, Cypress Bioscience, fibromyalgia

Roche Boosts Genentech Bid to $93 a Share

TheStreet.com

Friday, March 6, 2009 - 12:57pm

tags:

Roche, Genentech, buyouts

Aeterna Zentaris signs deal with Sanofi-Aventis

Yahoo/AP

Friday, March 6, 2009 - 12:55pm

tags:

Aeterna Zentaris, Sanofi, cetrorelix, benign prostatic hyperplasia

Merck's Jumpin' Januvia

CNBC

Friday, March 6, 2009 - 12:54pm

tags:

Merck, Januvia, Japan, Takeda, diabetes

Drug stocks climb in wake of U.S. payroll report

Marketwatch

Friday, March 6, 2009 - 12:53pm

tags:

drug stocks, OSI Pharmaceuticals, Bristol-Myers Squibb, Novartis, Schering Plough, Merck

Access reports positive results from Phase II ovarian cancer trial

Trading Markets

Friday, March 6, 2009 - 10:01am

tags:

Access Pharmaceuticals, ovarian cancer, ProLindac

BioDelivery Sciences: A Bet on FDA Approval

Seeking Alpha

Friday, March 6, 2009 - 9:58am

tags:

BioDelivery Sciences, FDA, Onsolis, cancer

Health Reform Summit: BIOs invitation lost in the mail

InVivo

Friday, March 6, 2009 - 9:56am

tags:

biotech, healthcare reform, Obama

Astellas Seeks to Oust CV Therapeutics Board in Takeover Bid

Bloomberg

Friday, March 6, 2009 - 9:54am

tags:

Astellas, CV Therapeutics, hostile takeover, buyouts

J&J’s Janssen Unit Marketed Risperdal Off-Label, Ex-Workers Say

Bloomberg

Friday, March 6, 2009 - 9:52am

tags:

JNJ, Janssen Pharmaceuticals, Risperdal, off-label, whistleblowers

No Bloom for Lilly

Yahoo/TheStreet.com

Friday, March 6, 2009 - 8:51am

tags:

Johnson & Johnson: Dividend Stock Analysis

Seeking Alpha

Friday, March 6, 2009 - 8:49am

tags:

Sepracor drug Lunesta fails in anxiety trial

Yahoo/AP

Friday, March 6, 2009 - 8:48am

tags:

Sepracor, Lunesta, anxiety, drug trials

Biotech's Defense Against Generics: FDA

TheStreet.com

Friday, March 6, 2009 - 8:47am

tags:

biotech, generics, FDA, Biogen Idec, Genentech, Genzyme, Merck, Pfizer, Bristol-Myers Squibb, Eli Lilly

The Dilemma for Drugmakers

Motley Fool

Friday, March 6, 2009 - 8:46am

tags:

Pfizer, Wyeth, Eli Lilly, devices, Supreme Court

Proteon pulls in $38M in VC, does Novartis deal worth up to $55M

Mass High Tech

Thursday, March 5, 2009 - 11:01am

tags:

Novartis, Proteon

GTx says FDA will rule on bone drug by Oct. 30

Yahoo/AP

Thursday, March 5, 2009 - 10:58am

tags:

GTx, FDA, prostate cancer, toremifene

Is the FDA a broken agency?

MSNBC

Thursday, March 5, 2009 - 10:56am

tags:

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels